VC investment in biotech blasts through $10B barrier in 2017

VC Investment

Vienna-based Hookipa Biotech has raised almost $60 million in an oversubscribed Series C funding. The investment will help the clinical stage company, which specializes in immunotherapy treatments for cancer and infectious diseases, bring two products to Phase I and II testing.

Read More